CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Hydrocodone Bitartrate and Homatropine Methylbromide

· ingredient homatropineAnticholinergics· HOMATROPINE METHYLBROMIDE 1.5 mg/1; HYDROCODONE BITARTRATE 5 mg/1; HOMATROPINE METHYLBROMIDE 1.5 mg/5mL; HYDROCODONE BITARTRATE 5 mg/5mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.95261
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per ML — the trend nobody else shows. 6 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other homatropine products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.

ProductNADAC / MLvs this
Hydromet$0.09910−$0.85350

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.